Bristol-Myers Squibb Glucophage XR

Metformin extended-release tablets approved for patients with type 2 diabetes. The product will be available in 500 mg, 850 mg and 1,000 mg tablets. Metformin immediate-release is recommended for two- or three-times daily dosing. Bristol is relying on the new formulation and its recently approved combo product Glucovance to protect its $1.9 bil. Glucophage franchise, which lost exclusivity in September